NEOPHARM INC
S-3, EX-27.1, 2000-08-24
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: NEOPHARM INC, S-3, EX-23.1, 2000-08-24
Next: VIRGINIA DAILY MUNICIPAL INCOME FUND INC, DEFS14A, 2000-08-24



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      25,296,283
<SECURITIES>                                         0
<RECEIVABLES>                                  175,079
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            25,828,421
<PP&E>                                         167,214
<DEPRECIATION>                                 111,166
<TOTAL-ASSETS>                              25,884,469
<CURRENT-LIABILITIES>                          511,917
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         2,391
<OTHER-SE>                                  25,370,161
<TOTAL-LIABILITY-AND-EQUITY>                25,884,469
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             1,297,588
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,297,588)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,297,588)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,297,588)
<EPS-BASIC>                                      (.12)
<EPS-DILUTED>                                    (.12)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission